Skip to main content
. 2020 Dec 3;13(1):619–645. doi: 10.18632/aging.202170

Table 1. Clinical baseline data and score grouping of 53 patients with OSs in GES21257 dataset.

Clinical features Cases, n (%) High 3-GRM score group, n (%) Low 3-GRM score group, n (%) P*
Patients(n) 53 28 25
Median age(range) 17 (14-19) 16.5(14-19) 17(13-19) 0.71
Gender
Female 19 (35.8) 7 (25.0) 12 (48.0) 0.08
Male 34 (64.2) 21 (75.0) 13 (52.0)
Histological Subtype
Osteoblastic 32 (60.4) 19 (67.9) 13 (52.0) 0.24
Others 21 (39.6) 9 (32.1) 12 (48.0)
Tumor location
Lower limb 44 (83.0) 23 (82.1) 21 (87.5) 0.88
upper limb 8 (15.1) 5 (17.9) 3 (12.5)
Unknow 1(1.89) - -
Huvos grade
I-II 29 (54.7) 14 (58.3) 15 (65.2) 0.85
III-IV 18 (34.0) 10 (41.7) 8 (34.8)
Unknow 6(11.3) - -
Metastases at diagnosis
No 39 (73.6) 20 (71.4) 19 (76.0) 0.95
Yes 14 (26.4) 8 (28.6) 6 (24.0)

*Comparison of high 3-GRM score group and low 3-GRM score group.